CURE hosted its second webinar that will focus on all the latest topics and trends for patients with lung cancer.
Lung cancer is the most common form of cancer in the United States and is the deadliest. However, the lung cancer landscape is evolving to meet the demands of the disease and find new ways to detect, prevent and treat lung cancer.
On Monday, June 8th, CURE® gathered top experts in the field of lung cancer for an informative lung cancer webinar focused on topics that were highly relevant to patients, caregivers and advocates, including current trends with lung cancer diagnoses, COVID-19 symptom overlap and minimizing risk, biomarker testing and more.
PRESENTING FACULTY include:
Stephen Liu, MD
Associate Professor of Medicine
Director, Thoracic Oncology
Director, Developmental Therapeutics
Georgetown University
Lombardi Comprehensive Cancer Center
Charu Aggarwal, MD
Leslye M. Heisler Assistant Professor for Lung Cancer Excellence
Abramson Cancer Center
University of Pennsylvania
Upal Basu Roy, PhD, MPH
Vice President of Research
LUNGevity Foundation
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More